Preprint
Link to published paper here
**
The Lancet: Efficacy of Repeat Immunoadsorption in Post-COVID ME/CFS Patients with Elevated B2-Adrenergic Receptor Autoantibodies: A Prospective Cohort Study
Abstract
Background: Since the pandemic, SARS-CoV-2 has become the leading trigger for ME/CFS...
Scheibenbogen et al
Abstract
There is increasing evidence for an autoimmune aetiology in post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). SARS-CoV-2 has now become the main trigger for ME/CFS. We have already conducted two small proof-of-concept studies of IgG...
Immune adsorption for the treatment of fatigue-dominant long-/post-COVID syndrome—a case series of standardized individual experimental therapy
Research letter / case series of 10 patients.
Announced English version not published yet.
So in lieu of an abstract here's a google translate link...
Repeat Immunoadsorption Post Covid ME/CFS
https://clinicaltrials.gov/ct2/show/NCT05629988
From Dr. Carmen Scheibenbogen's team at Charite University.
Their summary:
It's an observational study with no control group, so not rigorous. But after this study they want to do an RCT.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.